Cyril Planchais

Institut Pasteur — France

Medicine · Health Sciences

31h-index9.0kcitations98works7.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(51), COVID-19 Clinical Research Studies(34), Immune Cell Function and Interaction(24), SARS-CoV-2 detection and testing(22), Monoclonal and Polyclonal Antibodies Research(17)

Publications98 total

TMPRSS2 reduces antibody recognition of SARS-CoV-2 spike
2026Open Access
In vivo efficacy of combined human broadly neutralizing antibodies against hepatitis B virus
Cell Reports·2025Open Access
Optimized pipeline for generating highly potent neutralizing Affitins: Application to SARS-CoV-2 spike protein
International Journal of Biological Macromolecules·2025
Epitope-Driven Polyfunctional Divergence of SARS-CoV-2 RBD Antibodies
2025Open Access
Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms
RMD Open·2025Open Access
Generative model of SARS-CoV-2 variants under immune pressure unveils viral escape potential
2025· 3 citedOpen Access
Structural basis for hepatitis E virus neutralization by potent human antibodies
Science Advances·2025· 1 citedOpen Access
Optimized pipeline for generating highly potent neutralizing Affitins: application to SARS-CoV-2 spike protein
2025Open Access
HIV-1 broadly neutralizing antibodies demonstrate a high propensity for binding to heme
The Journal of Immunology·2025Open Access
Enhanced hepatitis B virus–specific immunity by combining neutralizing antibody therapy and DNA vaccination in a murine model of chronic hepatitis B virus infection
Hepatology·2024· 2 citedOpen Access
Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP.3.3 From Approved Monoclonal Antibodies
Pathogens and Immunity·2024· 42 citedOpen Access
High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination
Microbes and Infection·2024· 14 citedOpen Access
Intestinal newborn regulatory B cell antibodies modulate microbiota communities
Cell Host & Microbe·2024· 9 cited
Escape of SARS-CoV-2 variants KP1.1, LB.1 and KP3.3 from approved monoclonal antibodies
2024· 4 citedOpen Access
Temperature sensitivity of bat antibodies links metabolic state of bats with antigen-recognition diversity
Nature Communications·2024· 11 citedOpen Access
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2
iScience·2024· 11 citedOpen Access
High-resolution kinetics and cellular determinants of antibody response to SARS-CoV-2 over two years after COVID-19 vaccination
2024· 4 citedOpen Access
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells
Nature Communications·2024· 38 citedOpen Access
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
Journal of Virology·2023· 9 citedOpen Access
SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells
Nature Immunology·2023· 65 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Hugo Mouquet(42), Olivier Schwartz(33), Timothée Bruel(28), Florence Guivel‐Benhassine(25), Delphine Planas(23), Isabelle Staropoli(22), Françoise Porrot(20), Julian Buchrieser(18), Ludivine Grzelak(16), Laurent Hocqueloux(15), Jérémy Dufloo(15), Thiérry Prazuck(14), Etienne Simon‐Lorière(14), Maaran Michael Rajah(13), Jordan D. Dimitrov(13), Matthieu Prot(12), Hélène Péré(11), F.A. Rey(11), David Veyer(10), Aymeric Sève(10)